Cargando…

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

Platinum salts are active against metastatic triple negative breast cancer (mTNBC), and biomarkers to predict their effectiveness are urgently needed. In recent years, the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) have emerged as prognostic biomarkers in many ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vernieri, Claudio, Mennitto, Alessia, Prisciandaro, Michele, Huber, Veronica, Milano, Monica, Rinaldi, Lucia, Cona, Maria Silvia, Maggi, Claudia, Ferrari, Benvenuto, Manoukian, Siranoush, Mariani, Gabriella, Bianchi, Giulia, Capri, Giuseppe, Rivoltini, Licia, de Braud, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992181/ https://www.ncbi.nlm.nih.gov/pubmed/29880896 http://dx.doi.org/10.1038/s41598-018-27075-z

Ejemplares similares

Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer
por: Vernieri, Claudio, et al.
Publicado: (2020)

Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
por: Mennitto, Alessia, et al.
Publicado: (2020)

Fasting-mimicking diet plus chemotherapy in breast cancer treatment
por: Vernieri, Claudio, et al.
Publicado: (2020)

A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma
por: Frigerio, Simona, et al.
Publicado: (2014)

Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
por: Andreola, Giovanna, et al.
Publicado: (2002)

IMMUNOGLOBULIN SPOTS ON THE SURFACE OF RABBIT LYMPHOCYTES
por: Pernis, Benvenuto, et al.
Publicado: (1970)

Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations
por: Azzollini, Jacopo, et al.
Publicado: (2017)

The Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios in Predicting Response to Platinum-based Chemotherapy for Epithelial Ovarian Cancer
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2021)

IMMUNOGLOBULIN D AS A LYMPHOCYTE RECEPTOR
por: Rowe, David S., et al.
Publicado: (1973)

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
por: Grassi, Paolo, et al.
Publicado: (2017)

Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients
por: Vergani, Elisabetta, et al.
Publicado: (2021)

Proceedings: Triple chemotherapy in acute non-lymphocytic leukaemia.
por: Fennelly, J. J., et al.
Publicado: (1974)

Relationship between admission neutrophil/lymphocyte, thrombocyte/lymphocyte, and monocyte/lymphocyte ratios and 1-year mortality in geriatric hip fractures: Triple comparison
por: Tekin, Sezgin Bahadır, et al.
Publicado: (2022)

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
por: Grassi, Paolo, et al.
Publicado: (2016)

The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab
por: Ligorio, Francesca, et al.
Publicado: (2021)

BLOCKING AND REDISTRIBUTION ("CAPPING") OF ANTIGEN RECEPTORS ON T AND B LYMPHOCYTES BY ANTI-IMMUNOGLOBULIN ANTIBODY
por: Roelants, Georges, et al.
Publicado: (1973)

The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis
por: Provenzano, Leonardo, et al.
Publicado: (2023)

More insights into the immunosuppressive potential of tumor exosomes
por: Huber, Veronica, et al.
Publicado: (2008)

Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis
por: Lobefaro, Riccardo, et al.
Publicado: (2020)

Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
por: Čeprnja, Toni, et al.
Publicado: (2022)

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
por: Gorenšek, Rok, et al.
Publicado: (2023)

Glutathione restores normal cell activation and cell cycle progression in cis-platinum treated human lymphocytes.
por: Kubbies, M., et al.
Publicado: (1991)

Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
por: Huang, Hui-Shan, et al.
Publicado: (2018)

Everolimus versus alpelisib in advanced hormone receptor-positive HER2-negative breast cancer: targeting different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications
por: Vernieri, Claudio, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
por: García-Teijido, Paula, et al.
Publicado: (2016)

Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas
por: Hidalgo, Jose Villacorta, et al.
Publicado: (2014)

Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
por: Tian, Tian, et al.
Publicado: (2016)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization
por: Gomez-Macias, Gabriela Sofia, et al.
Publicado: (2020)

Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics
por: Balkenhol, Maschenka CA., et al.
Publicado: (2021)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)

Sarcopenia and monocyte-to-lymphocyte ratio as prognostic factors in early-stage breast cancer
por: Zattarin, Emma, et al.
Publicado: (2020)

The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients
por: Jia, Weijuan, et al.
Publicado: (2015)

PERCEPTION Trial protocol: Comparison of predictive and prognostic capacities of neutrophil, lymphocyte, and platelet counts and tumor-infiltrating lymphocytes in triple negative breast cancer
por: Lusho, Sejdi, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte and Monocyte-to-Lymphocyte Ratio in Bipolar Disorder
por: Fusar-Poli, Laura, et al.
Publicado: (2021)

Co-occurrence of Mayer-Rokitansky-Küster-Hauser syndrome and ovarian cancer: A case report and review of the literature
por: Villa, Roberta, et al.
Publicado: (2019)

Immune response markers in sentinel nodes may predict melanoma progression
por: Rodolfo, Monica, et al.
Publicado: (2014)

Defining the effects of prematurity on the lymphocyte transcriptome
por: Bhattacharya, Soumyaroop, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c58ufqeaodjuk47dsrb2h5mgvp